[ad_1]
DUBLIN, February 8, 2019 / PRNewswire / –
The conference "Dx & Rx Summit Extracellular Vesicles" has been added to ResearchAndMarkets.com & # 39; s offer.
The 2019 Extracellular Vesicle-Based Diagnostics and Therapeutics Summit (VSE) focuses on the emerging field of exosome deployment as diagnostics and engineering of extracellular exosomes and vesicles as a tool of choice. Administration of the therapeutic entities.
The ability to design electric vehicles and the ability of vehicles to target specific sites offers the opportunity to adapt therapeutic treatments with exquisite targeting capability and opens up a whole new clbad of therapeutic products that are clbadified as organic products and that do not have the side effects and toxicity badociated with medications. small therapies based on molecules.
This summit explores this topic and explores in depth the technological platforms, the targeted diseases and the clinical results obtained to date.
Agenda:
THURSDAY, March 28, 2019
10:00 – President of the conference
- Opening remarks by the conference chairman
- Lucia Languino, Professor of Cancer Biology, Thomas Jefferson University, the United States of America
- Title of the Summit Session: Emerging Issues in EV Diagnosis and Treatment
- Summit Presidents: Professor Lucia Languino and teacher Paul Robbins
10h30 – Extracellular vesicles and aging
- Paul Robbins, Professor in the Department of Biochemistry, Molecular Biology and Biophysics and at the Institute of Biology of Aging and Metabolism, University of Minnesota Medicine School, the United States of America
11:00 – Main presentation
- Diversity of extracellular vesicles to understand their diagnostic and therapeutic potential
- Jan Ltvall, Professor, University of Gothenburg; Founding President of ISEV, Sweden
This presentation will discuss the diversity of extracellular vesicles, mainly from a clinical point of view. Specifically, the presentation will show the presence of extracellular vesicles in tissues, especially healthy tissue, as well as different types of tumors. Data showing the presence of several types of electric vehicles in different types of tissues will be presented, as well as the possibilities of using this knowledge for clinical purposes.
11:30 – Main presentation
- Exosome Signaling in Brain Development
- Hollis ClineChair of Neuroscience and Professor Hahn of Neuroscience, The Scripps Research Institute, the United States of America
12:00 – Networking lunch in the exhibition hall and viewing posters
12h30 – Main presentation
- Subfractions of plasma extracellular vesicles for the diagnosis of cardiovascular diseases
- Dominique PV de Kleijn, Professor of Experimental Vascular Surgery, Professor of the Netherlands Institute of Cardiology, University Medical Center Utrecht, the Netherlands, Netherlands
13h00 – EV isolation of biofluids
- Shannon Pendergrast, Scientific Director, Ymir Genomics
- We will present several new products and methods to rapidly and efficiently isolate extracellular vesicles (EVs) from biofluids.
13h30 – Main presentation
- Exosome Engineering for the Delivery of Cytosolic Proteins: Principles and Therapeutic Applications
- Chulhee Choi, Professor and Chair of the Center for Biomedical Imaging of Korea's Higher Institute of Science and Technology (KAIST), President, Cellex Life Sciences, South Korea
14:00 – Induced tissue regeneration (ITR) with extracellular vesicles
- Dana Larocca, VP Discovery Research, AgeX Therapeutics, the United States of America
14:30 – Extracellular vesicles derived from stem cells can be specifically adjusted for soft tissue repair and wound healing
- John Ludlow, Executive Director, Regenerative Medicine, Zen-Bio, Inc., the United States of America
- Our research program is designed to provide critical proof-of-concept data demonstrating the manufacturing conditions and healing properties of extracellular vesicles derived from stem cells.
15:00 – Exosome adapted to HSP: presence in states of danger, disease and disturbance
- Michael Graner, Associate Professor, Department of Neurosurgery, University of Colorado Anschutz School of Medicine, the United States of America
15:30 – Nano-EV derived from stem cells of the human liver – A vast technological platform for cancer and regeneration
- Daniel Gau, Business Development Manager, Unicyte AG, Germany
16:00 – Propagation of aberrant pathogenic dipeptide repeat protein cells in C9orf72-related amyotrophic lateral sclerosis
- Davide Trotti, Professor, Scientific Director, ALS Weinberg Center, Vickie and Jack Farber Institute for Neuroscience, Thomas Jefferson University, the United States of America
16:30 – Single EV EV protein biomarker badysis by NanoView BiosciencesRoutine
- Clayton Deighan, Regional Sales Manager, NanoView Biosciences
17:00 – Extracellular vesicles become nuclear
- Aurelio Lorico, Professor of Pathology, Touro University Nevada, the United States of America
17:30 – Panel Discussion on Circulating Biomarkers and Liquid Biopsy
For more information on this conference, visit https://www.researchandmarkets.com/research/dbz4tq/one_day?w=5.
Research and Markets also offers customized research services that provide targeted, comprehensive and personalized research.
Media contact:
Research and markets
Laura Wood, Main director
[email protected]
For E.S.T office hours, call + 1-917-300-0470
For toll-free calls to the United States and Canada + 1-800-526-8630
For GMT office hours, call + 353-1-416-8900
American fax: 646-607-1907
Fax (outside the United States): + 353-1-481-1716
SOURCE Research and Markets
Related Links
http://www.researchandmarkets.com
Source link
